-
#ECTRIMS2018 – MS PATHS is Aiming for Remission as Treatment Goal
Read about an interview with Biogen’s vice president for development sciences, Rick Rudick, regarding the MS PATHS program. Click here to find our more about this.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.